Constantine, G. D., Revicki, D. A., Kagan, R., Simon, J. A., Graham, S., Bernick, B., & Mirkin, S. (2019). Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms. Menopause.
Chicago Stili AlıntıConstantine, Ginger D., Dennis A. Revicki, Risa Kagan, James A. Simon, Shelli Graham, Brian Bernick, ve Sebastian Mirkin. "Evaluation of Clinical Meaningfulness of Estrogen Plus Progesterone Oral Capsule (TX-001HR) On Moderate to Severe Vasomotor Symptoms." Menopause 2019.
MLA AlıntıConstantine, Ginger D., et al. "Evaluation of Clinical Meaningfulness of Estrogen Plus Progesterone Oral Capsule (TX-001HR) On Moderate to Severe Vasomotor Symptoms." Menopause 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..